EUVIMEDEUVIMED entdecken
Crossref

Ceramide concentrations in liver, plasma, and very low‐density lipoproteins of humans with severe obesity

Kelli A Lytle, Jin Ook Chung, Nikki C Bush, Jessica M Triay, Michael D Jensen iD

Lipids · 2023-05 · 58 (3) · 107-115

DOI: 10.1002/lipd.12367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lipids, online erschienen am 27.02.2023. Verfasst von Kelli A Lytle und 4 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Obesity, Morbid, Insulin Resistance. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NCRR NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigated the relationships between ceramide species concentrations in liver, plasma and very low‐density lipoproteins (VLDL) particles of humans with obesity as well as the relationships between hepatic fat content and hepatic ceramide concentrations and proportional distribution. Twenty‐five obese (body mass index >35 kg/m 2 ) adults participated in this study. Plasma, VLDL and hepatocellular ceramide concentrations were measured by liquid chromatography/tandem mass spectrometry. The proportionate distribution of measured ceramide species differed between liver, whole plasma and the VLDL fraction. We found significant, positive correlations between the proportion of C14:0, C18:0, C20:0 and C24:1 ceramide in the liver and whole plasma ( γ = 0.491, p = 0.013; γ = 0.573, p = 0.003; γ = 0.479, p = 0.015; γ = 0.716, p = 0.00006; respectively). In contrast, only the proportional contribution of C24:1 ceramide correlated positively between VLDL and liver ( γ = 0.425, p = 0.013). The percent hepatic fat correlated positively with the proportion of C18:1, C18:0 and C20:0 hepatic ceramides ( γ = 0.415, p = 0.039; γ = 0.426, p = 0.034; γ = 0.612, p = 0.001; respectively), but not with total hepatic ceramide concentration. The proportions of whole plasma ceramide subspecies, especially C14:0, C18:0, C20:0 and C24:1chain length, are reflective of those of hepatic ceramide subspecies in obese humans; these appear to be markers of hepatic ceramide species composition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Obesity, MorbidInsulin ResistanceHumansAdultCeramidesLipoproteins, VLDLObesityLiverLipoproteins, LDL

Stichwörter der Autor:innen

VLDLceramidesfatty liverobesity

Substanzen

CeramidesLipoproteins, VLDLLipoproteins, LDL

Autor:innen und Institutionen

  • Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Bendigo Health, Bendigo, Victoria, Australia.

ORCID-Profile: Michael D Jensen

Förderung

  • NCRR NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • National Institutes of Health
  • American Diabetes Association

Zitieren

APA

Lytle, K. A., Chung, J. O., Bush, N. C., Triay, J. M., & Jensen, M. D. (2023). Ceramide concentrations in liver, plasma, and very low‐density lipoproteins of humans with severe obesity. Lipids, 58(3), 107-115. https://doi.org/10.1002/lipd.12367

Vancouver

Lytle KA, Chung JO, Bush NC, Triay JM, Jensen MD. Ceramide concentrations in liver, plasma, and very low‐density lipoproteins of humans with severe obesity. Lipids. 2023;58(3):107-115. doi:10.1002/lipd.12367

BibTeX
@article{Lytle2023,
  author = {Lytle, Kelli A and Chung, Jin Ook and Bush, Nikki C and Triay, Jessica M and Jensen, Michael D},
  title = {Ceramide concentrations in liver, plasma, and very low‐density lipoproteins of humans with severe obesity},
  journal = {Lipids},
  year = {2023},
  volume = {58},
  number = {3},
  pages = {107--115},
  doi = {10.1002/lipd.12367}
}
Kostenlos starten →